Ultiva Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-913

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ultiva (NDC 67457-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remifentanil Hydrochloride Structural Formula (Image 01)

Chemical structure of Remifentanil Hydrochloride, the active ingredient in Ultiva injection powder, lyophilized, for intravenous use. The structure shows the molecular connectivity including functional groups and rings characteristic of Remifentanil.*

FDA Label Image

Figure 1: Recovery Of Respiratory Drive After Equipotent* Doses Of Ultiva And Alfentanil Using Co2-stimulated Minute Ventilation In Adult Volunteers (±1.5 Sem) (Image 02)

A line graph comparing minute ventilation (% of baseline) over time (minutes) during and after infusion of Ultiva (remifentanil hydrochloride) and Alfentanil. The graph shows ventilation decreasing during infusion, with differences in recovery patterns post-infusion between Ultiva and Alfentanil groups, including error bars indicating variability.*

FDA Label Image

Figure 2: Mean Concentration (sd) Versus Time (Image 03)

A line graph showing mean concentration (ng/mL) of two drugs, Alfentanil and Ultiva, measured over time (minutes). The y-axis is logarithmic, and two curves show concentration changes: one for Alfentanil at 0.5 mcg/kg/min and one for Ultiva at 0.05 mcg/kg/min, with error bars indicating variability.*

FDA Label Image

Ultiva Injection 1 mg Carton Label (Image 04)

Packaging label for Ultiva (remifentanil HCl) for Injection, 1 mg strength. The label indicates 10 single-dose vials of lyophilized powder for intravenous use. The labeler is Mylan Institutional LLC, and the packaging includes dosage and storage instructions, barcodes, and trademarks including novaplus®.*

FDA Label Image

Ultiva Injection 2 mg Carton Label (Image 05)

Packaging label for Ultiva 2 mg (equivalent to 2 mg remifentanil) injection powder, lyophilized, for intravenous use. The label indicates 10 single-dose vials of 2 mg each. The labeler is Mylan Institutional LLC, with branding references to novaplus. Storage, dosage, and reconstitution instructions are partially visible on the label.*

FDA Label Image

Ultiva Injection 5 mg Carton Label (Image 06)

Packaging label for Ultiva (remifentanil HCl) injection, powder, lyophilized, for solution, 5 mg strength equivalent to 5 mg of remifentanil. The label states it is for intravenous use only and contains 10 x 5 mg single-dose vials. The product is labeled for Mylan Institutional LLC. Storage instructions, usage directions, and manufacturer information are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.